Flynn James E 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-29 5:24 pm Sale |
2022-12-29 | 13G | Xilio Therapeutics, Inc. XLO |
Flynn James E | 0 0.000% |
-2,154,061 (Position Closed) |
Filing |
| 2022-02-11 4:14 pm Sale |
2021-12-31 | 13G | Xilio Therapeutics, Inc. XLO |
Flynn James E | 2,154,061 7.840% |
-133,883 (-5.85%) |
Filing |
| 2021-10-26 7:35 pm Purchase |
2021-10-26 | 13G | Xilio Therapeutics, Inc. XLO |
Flynn James E | 2,287,944 8.580% |
2,287,944 (New Position) |
Filing |